Farms.com Home   Ag Industry News

Merck unveils SEQUIVITY swine vaccine for disease control

By Farms.com

Merck Animal Health launches SEQUIVITY with Microsol Diluvac Forte, a revolutionary vaccine for swine health. Powered by RNA Particle Technology and MDF adjuvant, SEQUIVITY offers tailored protection against prevalent swine diseases.

With SEQUIVITY, swine producers gain access to a flexible and rapid vaccination solution. The platform's immuno-precision capabilities enable targeted vaccine production, addressing evolving disease challenges with accuracy.

Dr. Jeremy Maurer, Associate Director of U.S. Livestock Insights and Outcomes for Merck Animal Health, highlights SEQUIVITY’s role in advancing swine health management. Merck's commitment to innovation ensures effective solutions for the evolving needs of swine producers.

SEQUIVITY vaccines are easy to administer, mixed at the point of use from frozen antigen and diluent bottles. This user-friendly format allows for customized dosing and efficient disease control in swine herds. 

Merck provides comprehensive support for SEQUIVITY users, including access to a web-based dashboard for data-driven decision-making. Swine producers and veterinarians can leverage insights to optimize herd health.


Trending Video

Dr. Cordell Young: Innovation Strategies in Swine

Video: Dr. Cordell Young: Innovation Strategies in Swine

In this episode of The Swine It Podcast Show Canada, Dr. Cordell Young, a partner at Precision Veterinary Services, offers valuable insights into the role of innovation in the swine industry. Dr. Young breaks down the different types of innovation and discusses how they can be applied to enhance business models, streamline processes, and better connect with customers in the Canadian swine sector. Stay ahead in this competitive market—tune in now on your favorite platform to gain practical knowledge and stay informed!